0001209191-20-037129.txt : 20200616
0001209191-20-037129.hdr.sgml : 20200616
20200616200858
ACCESSION NUMBER: 0001209191-20-037129
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200612
FILED AS OF DATE: 20200616
DATE AS OF CHANGE: 20200616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KANAYA SUSAN M
CENTRAL INDEX KEY: 0001226064
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 20967826
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-12
0
0001340652
ChemoCentryx, Inc.
CCXI
0001226064
KANAYA SUSAN M
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW
CA
94043
0
1
0
0
EVP, CFO and Sec.
Common Stock
2020-06-12
4
M
0
30000
8.19
A
121317
D
Common Stock
2020-06-12
4
M
0
20000
11.02
A
141317
D
Common Stock
2020-06-12
4
S
0
50000
64.5807
D
91317
D
Common Stock
104930
I
Kanaya Family Trust U/A Dtd 10/17/2012
Stock Option (right to buy)
8.19
2020-06-12
4
M
0
30000
D
2025-02-23
Common Stock
30000
67132
D
Stock Option (right to buy)
11.02
2020-06-12
4
M
0
20000
D
2029-03-04
Common Stock
20000
60000
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $64.50 to $64.80 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
As of June 12, 2020, and prior to this transaction, the exercised options were fully vested.
Not applicable.
/s/ Susan M. Kanaya
2020-06-16